|
시장보고서
상품코드
1449250
세계 에소메프라졸(Esomeprazole) 시장 : 점유율, 시장 규모, 동향, 산업 분석 보고서 - 제품별, 용도별, 유통 채널별, 지역별, 부문별 예측(2024-2032년)Esomeprazole Market Share, Size, Trends, Industry Analysis Report, By Product (Capsules, Tablets, Injections, Others); By Application; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032 |
||||||
Polaris Market Research의 최근 조사에 따르면 에소메프라졸 시장 규모는 2032년까지 28억 7,207만 달러에 이를 것으로 예상됩니다. 이 설문조사 보고서는 현재 시장 역학을 자세히 파악하고 향후 시장 성장에 대한 분석을 제공합니다.
에소메프라졸은 위궤양, 위식도 역류증, 졸린저 엘리슨 증후군 등 세계 유병률로 인한 세계 헬스케어 공간에서 중요성을 증가시키고 있습니다. 위산을 감소시키는 에소메프라졸의 높은 효능은 앞으로 수년간 에소메프라졸 시장의 확대에 박차를 가하고 있습니다.
에소메프라졸은 치료 과정에서 널리 이용되기 때문에 사람들의 위장 장애 증가는 에소메프라졸의 큰 수요를 나타냅니다. 2023년 조사에 따르면 COVID-19에 감염된 사람은 그 해에 위식도 역류증을 일으킬 위험이 높고(39%) COVID-19 바이러스에 감염되지 않은 사람과 일치 감염이 계속됩니다. 이 조사는 조사 기간 동안 시장의 새로운 성장 기회를 보여줍니다.
마켓플레이스에서 에소메프라졸 생산에 진입하는 시장 기업의 출현은 앞으로 수년간 에소메프라졸 시장 규모를 높일 가능성이 높습니다. 예를 들어 2023년 Granules India Limited는 미국 식품의약국(US FDA)으로부터 USP, 20mg, 40mg의 강도의 에소메프라졸 마그네슘 지연 방출 캡슐의 약식 신약 신청(ANDA)의 승인을 받았습니다. 이러한 노력은 이 약 시장 공급을 강화할 것으로 기대됩니다.
제약회사는 위궤양과 십이지장 궤양을 포함한 수많은 미해결 건강 문제에 효과적인 약물을 혁신하기 위해 연구개발 활동을 강화하고 있습니다. 예를 들어 2023년 4월 Acums 의약품은 H. pylori 감염과 십이지장 궤양의 치료를 위한 새로운 콤비킷을 발표했습니다. 이러한 신흥국 시장의 개척은 세계에서 새로운 에소메프라졸 시장 기회를 창출할 가능성이 높습니다.
인터넷에 대한 액세스 기회가 증가함에 따라 세계에서 정보의 비대칭성이 저하되고 의약품에 대한 지식의 향상이 촉진되었습니다. 인구의 위와 관련된 문제 증가는 예측 기간 동안 마켓플레이스에서 시판약을 통해 에소메프라졸 의약품의 큰 수요를 촉진하는 것으로 보입니다.
더 많은 기업들이 의약품, 특히 에소메프라졸의 생산에 진출하고 있으며, 시장의 확대를 이끌고 있습니다. 예를 들어 2023년 10월, Marksans는 에소메프라졸 마그네슘 캡슐의 제조 승인을 받았습니다.
에소메프라졸 시장 보고서 하이라이트
캡슐은 정제보다 효과가 우수하기 때문에 향후 수년간 가장 높은 성장이 예상된다.
위식도 역류증 시장은 위산 역류 증례 증가로 최대 시장 점유율을 차지
병원 및 제약 약국 부문은 환자 접근이 증가함에 따라 더 큰 수익 점유율을 차지할 것으로 예상됩니다.
APAC는 노인 인구의 존재로 인해 예측 기간 동안 가장 빠른 성장을 기록할 것으로 예상됩니다.
목차
소개
- 보고서 설명
- 연구의 목적
- 시장 범위
- 가정
- 이해관계자
제2장 주요 요약
제3장 조사 방법
제4장 세계 에소메프라졸 시장에 대한 인사이트
- 에소메프라졸 시장 - 유통 채널의 스냅샷
- 에소메프라졸 시장 역학
- 성장 촉진요인과 기회
- 위장염 증례 증가가 시장을 견인
- 식생활의 변화와 비만 증가가 시장을 견인
- 억제요인과 과제
- 에소메프라졸과 관련된 부작용은 시장 성장을 방해할 가능성이 높다
- 성장 촉진요인과 기회
- PESTEL 분석
- 에소메프라졸 시장 유통 채널의 동향
- 밸류체인 분석
- COVID-19 감염의 영향 분석
제5장 세계 에소메프라졸 시장 : 용도별
- 주요 조사 결과
- 소개
- 위식도 역류증
- 미란성 식도염
- 소화성 궤양
- 십이지장 궤양
- 졸린저 엘리슨 증후군
- 기타
제6장 세계 에소메프라졸 시장 : 제품별
- 주요 조사 결과
- 소개
- 캡슐
- 태블릿
- 주사
- 기타
제7장 세계 에소메프라졸 시장 : 유통 채널별
- 주요 조사 결과
- 소개
- 병원과 약국
- 온라인 약국
- OTC
제8장 세계 에소메프라졸 시장 : 지역별
- 주요 조사 결과
- 소개
- 에소메프라졸 시장 평가, 지역별(2019년-2032년)
- 에소메프라졸 시장-북미
- 북미 : 에소메프라졸 시장 : 용도별(2019년-2032년)
- 북미 : 에소메프라졸 시장 : 유통 채널별(2019년-2032년)
- 북미 : 에소메프라졸 시장 : 제품별(2019년-2032년)
- 에소메프라졸 시장-미국
- 에소메프라졸 시장- 캐나다
- 에소메프라졸 시장 - 유럽
- 유럽: 에소메프라졸 시장 : 용도별(2019년-2032년)
- 유럽: 에소메프라졸 시장 : 유통 채널별(2019년-2032년)
- 유럽: 에소메프라졸 시장 : 제품별(2019년-2032년)
- 에소메프라졸 시장 - 영국
- 에소메프라졸 시장-프랑스
- 에소메프라졸 시장 - 독일
- 에소메프라졸 시장 - 이탈리아
- 에소메프라졸 시장-스페인
- 에소메프라졸 시장-네덜란드
- 에소메프라졸 시장 - 러시아
- 에소메프라졸 시장 - 아시아태평양
- 아시아태평양: 에소메프라졸 시장 : 용도별(2019년-2032년)
- 아시아태평양: 에소메프라졸 시장 : 유통 채널별(2019년-2032년)
- 아시아태평양: 에소메프라졸 시장 : 제품별(2019년-2032년)
- 에소메프라졸 시장- 중국
- 에소메프라졸 시장 - 인도
- 에소메프라졸 시장 - 말레이시아
- 에소메프라졸 시장 - 일본
- 에소메프라졸 시장- 인도네시아
- 에소메프라졸 시장 - 한국
- 에소메프라졸 시장 - 중동 및 아프리카
- 중동 및 아프리카: 에소메프라졸 시장 : 용도별(2019년-2032년)
- 중동 및 아프리카: 에소메프라졸 시장 : 유통 채널별(2019년-2032년)
- 중동 및 아프리카: 에소메프라졸 시장 : 제품별(2019년-2032년)
- 에소메프라졸 시장 - 사우디아라비아
- 에소메프라졸 시장 - 아랍에미리트(UAE)
- 에소메프라졸 시장 - 이스라엘
- 에소메프라졸 시장 - 남아프리카
- 에소메프라졸 시장-라틴아메리카
- 라틴아메리카: 에소메프라졸 시장 : 용도별(2019년-2032년)
- 라틴아메리카: 에소메프라졸 시장 : 유통 채널별(2019년-2032년)
- 라틴아메리카: 에소메프라졸 시장 : 제품별(2019년-2032년)
- 에소메프라졸 시장- 멕시코
- 에소메프라졸 시장 - 브라질
- 에소메프라졸 시장- 아르헨티나
제9장 경쟁 구도
- 확장 및 인수 분석
- 확대
- 인수
- 제휴/협업/합의/공개
제10장 기업 프로파일
- Actavis(US)
- AstraZeneca AB(UK)
- Blaskov(Columbia)
- CQ Lummy(China)
- KernPharm(Spain)
- Mepha(India)
- Mylan(US)
- Sandoz(Switzerland)
- Sanofi(France)
- Saval Pharmaceutical(Chile)
- Stada Arzneimittel AG(Germany)
- Teva Pharmaceuticals(Israel)
The global esomeprazole market size is expected to reach USD 2,872.07 million by 2032, according to a new study by Polaris Market Research. The report "Esomeprazole Market Share, Size, Trends, Industry Analysis Report, By Product (Capsules, Tablets, Injections, Others); By Application; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Esomeprazole is gaining importance in the global healthcare space attributable to the prevalence of gastric ulcers, gastroesophageal reflux disease, Zollinger-Ellison syndrome, and more in the world. The higher effectiveness of esomeprazole in lowering acid in the stomach among humans is a contributing factor fueling the expansion of the esomeprazole market in the coming years.
The increasing gastrointestinal problems in people are showcasing the significant demand for esomeprazole, as it is widely utilized in the treatment process. According to the 2023 study, people infected with COVID-19 have a higher risk (39%) of developing gastroesophageal reflux disease in the year, followed by the infection in line with the people who are not infected by the COVID-19 virus. This study demonstrates new growth opportunities for the market during the study period.
The emergence of market players entering the production of esomeprazole in the marketplace is likely to enhance the esomeprazole market size in the coming years. For instance, in 2023, Granules India Limited received the approval of an abbreviated new drug application (ANDA) for Esomeprazole Magnesium delayed-release capsules for USP, 20 mg, and 40mg strengths from the US Food and Drug Administration (US FDA). These initiatives are expected to enhance the supply of this drug on the market.
Pharmaceutical companies are boosting research and development activities to innovate effective medication for the numerous unresolved health issues, including gastric and duodenal ulcers. For instance, in April 2023, Akums Drugs and Pharmaceuticals introduced the new Combikit for the treatment of H. pylori infection and duodenal ulcer. These developments are likely to create new esomeprazole market opportunities around the world.
The increased accessibility of the internet lowered the chance of asymmetry of information in the world, driving enhanced knowledge of medicines. The rising stomach-related issues in the population are likely to facilitate significant demand for the esomeprazole drug through the over-the-counter option in the marketplace during the forecast period.
More companies are entering into the production of pharmaceutical drugs, specifically esomeprazole, driving the expansion of the global market. For instance, in October 2023, Marksans received approval to produce esomeprazole magnesium capsules.
Esomeprazole Market Report Highlights
Capsules segment is anticipated to witness the highest growth in the coming years due to its superior action over tablets.
Gastroesophageal reflux disease segment accounted for the largest market share owing to the rising incidence of acid reflux cases.
Hospitals & Clinical Pharmacies segment is projected to experience a larger revenue share attributable to the increased patient access.
APAC is projected to register the fastest growth during the forecast period attributable to the presence of the elderly population.
The global players include Actavis, AstraZeneca AB, Blaskov, CQ Lummy, KernPharm, Mepha, Mylan, Sandoz, Sanofi, Saval Pharmaceutical, Stada, & Teva.
Polaris Market Research has segmented the esomeprazole market report based on product, application, distribution channel and region:
Esomeprazole, Product Outlook (Revenue - USD Billion, 2019 - 2032)
- Capsules
- Tablets
- Injections
- Others
Esomeprazole, Application Outlook (Revenue - USD Billion, 2019 - 2032)
- Gastroesophageal reflux disease
- Erosive Esophagitis
- Peptic Ulcers
- Duodenal Ulcers
- Zollinger-Ellison Syndrome
- Others
Esomeprazole, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)
- Hospitals & Clinical Pharmacies
- Online Pharmacies
- OTC
Esomeprazole, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Table of Contents
Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Esomeprazole Market Insights
- 4.1. Esomeprazole Market - Distribution Channel Snapshot
- 4.2. Esomeprazole Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising gastroenteritis cases drives the market
- 4.2.1.2. The changing eating patterns and rising obesity drives the market
- 4.2.2. Restraints and Challenges
- 4.2.2.1. The side-effects associated with esomeprazole are likely to hinder market growth
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Esomeprazole Market Distribution Channel Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Esomeprazole Market, by Application
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Esomeprazole Market, by Application, 2019-2032 (USD Million)
- 5.3. Gastroesophageal reflux disease
- 5.3.1. Global Esomeprazole Market, by Gastroesophageal reflux disease, by Region, 2019-2032 (USD Million)
- 5.4. Erosive Esophagitis
- 5.4.1. Global Esomeprazole Market, by Erosive Esophagitis, by Region, 2019-2032 (USD Million)
- 5.5. Peptic Ulcers
- 5.5.1. Global Esomeprazole Market, by Peptic Ulcers, by Region, 2019-2032 (USD Million)
- 5.6. Duodenal Ulcers
- 5.6.1. Global Esomeprazole Market, by Duodenal Ulcers, by Region, 2019-2032 (USD Million)
- 5.7. Zollinger-Ellison Syndrome
- 5.7.1. Global Esomeprazole Market, by Zollinger-Ellison Syndrome, by Region, 2019-2032 (USD Million)
- 5.8. Others
- 5.8.1. Global Esomeprazole Market, by Others, by Region, 2019-2032 (USD Million)
6. Global Esomeprazole Market, by Product
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Esomeprazole Market, by Product, 2019-2032 (USD Million)
- 6.3. Capsules
- 6.3.1. Global Esomeprazole Market, by Capsules, by Region, 2019-2032 (USD Million)
- 6.4. Tablets
- 6.4.1. Global Esomeprazole Market, by Tablets, by Region, 2019-2032 (USD Million)
- 6.5. Injections
- 6.5.1. Global Esomeprazole Market, by Injections, by Region, 2019-2032 (USD Million)
- 6.6. Others
- 6.6.1. Global Esomeprazole Market, by Others, by Region, 2019-2032 (USD Million)
7. Global Esomeprazole Market, by Distribution Channel
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
- 7.3. Hospitals & Clinical Pharmacies
- 7.3.1. Global Esomeprazole Market, by Hospitals & Clinical Pharmacies, By Region, 2019-2032 (USD Million)
- 7.4. Online Pharmacies
- 7.4.1. Global Esomeprazole Market, by Online Pharmacies, By Region, 2019-2032 (USD Million)
- 7.5. OTC
- 7.5.1. Global Esomeprazole Market, by OTC, By Region, 2019-2032 (USD Million)
8. Global Esomeprazole Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Esomeprazole Market Assessment, By Geography, 2019-2032 (USD Million)
- 8.3. Esomeprazole Market - North America
- 8.3.1. North America: Esomeprazole Market, by Application, 2019-2032 (USD Million)
- 8.3.2. North America: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.3.3. North America: Esomeprazole Market, by Product, 2019-2032 (USD Million)
- 8.3.4. Esomeprazole Market - U.S.
- 8.3.4.1. U.S.: Esomeprazole Market, by Application, 2019-2032 (USD Million)
- 8.3.4.2. U.S.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.3.4.3. U.S.: Esomeprazole Market, by Product, 2019-2032 (USD Million)
- 8.3.5. Esomeprazole Market - Canada
- 8.3.5.1. Canada: Esomeprazole Market, by Application, 2019-2032 (USD Million)
- 8.3.5.2. Canada.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.3.5.3. Canada: Esomeprazole Market, by Product, 2019-2032 (USD Million)
- 8.4. Esomeprazole Market - Europe
- 8.4.1. Europe: Esomeprazole Market, by Application, 2019-2032 (USD Million)
- 8.4.2. Europe.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.4.3. Europe: Esomeprazole Market, by Product, 2019-2032 (USD Million)
- 8.4.4. Esomeprazole Market - UK
- 8.4.4.1. UK: Esomeprazole Market, by Application, 2019-2032 (USD Million)
- 8.4.4.2. UK.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.4.4.3. UK: Esomeprazole Market, by Product, 2019-2032 (USD Million)
- 8.4.5. Esomeprazole Market - France
- 8.4.5.1. France: Esomeprazole Market, by Application, 2019-2032 (USD Million)
- 8.4.5.2. France.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.4.5.3. France: Esomeprazole Market, by Product, 2019-2032 (USD Million)
- 8.4.6. Esomeprazole Market - Germany
- 8.4.6.1. Germany: Esomeprazole Market, by Application, 2019-2032 (USD Million)
- 8.4.6.2. Germany.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.4.6.3. Germany: Esomeprazole Market, by Product, 2019-2032 (USD Million)
- 8.4.7. Esomeprazole Market - Italy
- 8.4.7.1. Italy: Esomeprazole Market, by Application, 2019-2032 (USD Million)
- 8.4.7.2. Italy.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.4.7.3. Italy: Esomeprazole Market, by Product, 2019-2032 (USD Million)
- 8.4.8. Esomeprazole Market - Spain
- 8.4.8.1. Spain: Esomeprazole Market, by Application, 2019-2032 (USD Million)
- 8.4.8.2. Spain.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.4.8.3. Spain: Esomeprazole Market, by Product, 2019-2032 (USD Million)
- 8.4.9. Esomeprazole Market - Netherlands
- 8.4.9.1. Netherlands: Esomeprazole Market, by Application, 2019-2032 (USD Million)
- 8.4.9.2. Netherlands.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.4.9.3. Netherlands: Esomeprazole Market, by Product, 2019-2032 (USD Million)
- 8.4.10. Esomeprazole Market - Russia
- 8.4.10.1. Russia: Esomeprazole Market, by Application, 2019-2032 (USD Million)
- 8.4.10.2. Russia.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.4.10.3. Russia: Esomeprazole Market, by Product, 2019-2032 (USD Million)
- 8.5. Esomeprazole Market - Asia Pacific
- 8.5.1. Asia Pacific: Esomeprazole Market, by Application, 2019-2032 (USD Million)
- 8.5.2. Asia Pacific.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.5.3. Asia Pacific: Esomeprazole Market, by Product, 2019-2032 (USD Million)
- 8.5.4. Esomeprazole Market - China
- 8.5.4.1. China: Esomeprazole Market, by Application, 2019-2032 (USD Million)
- 8.5.4.2. China.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.5.4.3. China: Esomeprazole Market, by Product, 2019-2032 (USD Million)
- 8.5.5. Esomeprazole Market - India
- 8.5.5.1. India: Esomeprazole Market, by Application, 2019-2032 (USD Million)
- 8.5.5.2. India.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.5.5.3. India: Esomeprazole Market, by Product, 2019-2032 (USD Million)
- 8.5.6. Esomeprazole Market - Malaysia
- 8.5.6.1. Malaysia: Esomeprazole Market, by Application, 2019-2032 (USD Million)
- 8.5.6.2. Malaysia.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.5.6.3. Malaysia: Esomeprazole Market, by Product, 2019-2032 (USD Million)
- 8.5.7. Esomeprazole Market - Japan
- 8.5.7.1. Japan: Esomeprazole Market, by Application, 2019-2032 (USD Million)
- 8.5.7.2. Japan.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.5.7.3. Japan: Esomeprazole Market, by Product, 2019-2032 (USD Million)
- 8.5.8. Esomeprazole Market - Indonesia
- 8.5.8.1. Indonesia: Esomeprazole Market, by Application, 2019-2032 (USD Million)
- 8.5.8.2. Indonesia.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.5.8.3. Indonesia: Esomeprazole Market, by Product, 2019-2032 (USD Million)
- 8.5.9. Esomeprazole Market - South Korea
- 8.5.9.1. South Korea: Esomeprazole Market, by Application, 2019-2032 (USD Million)
- 8.5.9.2. South Korea.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.5.9.3. South Korea: Esomeprazole Market, by Product, 2019-2032 (USD Million)
- 8.6. Esomeprazole Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Esomeprazole Market, by Application, 2019-2032 (USD Million)
- 8.6.2. Middle East & Africa.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.6.3. Middle East & Africa: Esomeprazole Market, by Product, 2019-2032 (USD Million)
- 8.6.4. Esomeprazole Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Esomeprazole Market, by Application, 2019-2032 (USD Million)
- 8.6.4.2. Saudi Arabia.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.6.4.3. Saudi Arabia: Esomeprazole Market, by Product, 2019-2032 (USD Million)
- 8.6.5. Esomeprazole Market - UAE
- 8.6.5.1. UAE: Esomeprazole Market, by Application, 2019-2032 (USD Million)
- 8.6.5.2. UAE.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.6.5.3. UAE: Esomeprazole Market, by Product, 2019-2032 (USD Million)
- 8.6.6. Esomeprazole Market - Israel
- 8.6.6.1. Israel: Esomeprazole Market, by Application, 2019-2032 (USD Million)
- 8.6.6.2. Israel.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.6.6.3. Israel: Esomeprazole Market, by Product, 2019-2032 (USD Million)
- 8.6.7. Esomeprazole Market - South Africa
- 8.6.7.1. South Africa: Esomeprazole Market, by Application, 2019-2032 (USD Million)
- 8.6.7.2. South Africa.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.6.7.3. South Africa: Esomeprazole Market, by Product, 2019-2032 (USD Million)
- 8.7. Esomeprazole Market - Latin America
- 8.7.1. Latin America: Esomeprazole Market, by Application, 2019-2032 (USD Million)
- 8.7.2. Latin America.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.7.3. Latin America: Esomeprazole Market, by Product, 2019-2032 (USD Million)
- 8.7.4. Esomeprazole Market - Mexico
- 8.7.4.1. Mexico: Esomeprazole Market, by Application, 2019-2032 (USD Million)
- 8.7.4.2. Mexico.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.7.4.3. Mexico: Esomeprazole Market, by Product, 2019-2032 (USD Million)
- 8.7.5. Esomeprazole Market - Brazil
- 8.7.5.1. Brazil: Esomeprazole Market, by Application, 2019-2032 (USD Million)
- 8.7.5.2. Brazil.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.7.5.3. Brazil: Esomeprazole Market, by Product, 2019-2032 (USD Million)
- 8.7.6. Esomeprazole Market - Argentina
- 8.7.6.1. Argentina: Esomeprazole Market, by Application, 2019-2032 (USD Million)
- 8.7.6.2. Argentina.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.7.6.3. Argentina: Esomeprazole Market, by Product, 2019-2032 (USD Million)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Actavis (US)
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. AstraZeneca AB (UK)
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Blaskov (Columbia)
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. CQ Lummy (China)
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. KernPharm (Spain)
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Mepha (India)
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Mylan (US)
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Sandoz (Switzerland)
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Sanofi (France)
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Saval Pharmaceutical (Chile)
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Stada Arzneimittel AG (Germany)
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Teva Pharmaceuticals (Israel)
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
